Form D · Biotechnology

TGS Knee Innovations, Inc

Plymouth, MN · CIK 0001484117

Offering snapshot reported May 17, 2011 · SEC filing

Reported sold: $1.53M
Investors reported: 16
Minimum accepted: $0
First sale: Feb 24, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$702,000 → $1,532,250
Reported investors8 → 16

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 17, 2011	Amendment	$1,532,250	$830,250vs Mar 11, 2011	16	SEC filing
Mar 11, 2011	Initial	$702,000	No comparison	8	SEC filing
Feb 18, 2010	Initial	$600,000	No comparison	3	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 05, 06, 46
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: Not reported

Source: Form D, filed May 17, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael A. Bates	Director
Ralph A. Cusick	Director
Gerard A. Engh	Director
Gerald A Engh	Director, Promoter
Wesley D Johnson	Director, Executive, Promoter
Rudy Mazocchi	Director
Rudy Mazzocchi	Director
Michael Renner	Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

15800 32 Nd Avenue North Suite 100
Plymouth, MN, 55447